PML regulates p53 acetylation and premature senescence induced by oncogenic Ras (original) (raw)

• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 ( 1997).
  Article CAS Google Scholar
• Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973–2983 (1998).
  Article CAS Google Scholar
• de The, H., Chomienne, C., Lanotte, M., Degos, L. & Dejean, A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347, 558– 561 (1990).
  Article ADS CAS Google Scholar
• Borrow, J., Goddard, A. D., Sheer, D. & Solomon, E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249, 1577– 1580 (1990).
  Article ADS CAS Google Scholar
• Fagioli, M. et al. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Oncogene 16, 2905–2913 ( 1998).
  Article CAS Google Scholar
• Le, X. F., Yang, P. & Chang, K. S. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271, 130–135 (1996).
  Article CAS Google Scholar
• Liu, J. H., Mu, Z. M. & Chang, K. S. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J. Exp. Med. 181, 1965 –1973 (1995).
  Article CAS Google Scholar
• Wang, Z. G. et al. Role of PML in cell growth and the retinoic acid pathway. Science 279, 1547–1551 (1998).
  Article ADS CAS Google Scholar
• Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363–9367 (1995).
  Article ADS CAS Google Scholar
• Dyck, J. A. et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333– 343 (1994).
  Article CAS Google Scholar
• Metz, T., Harris, A. W. & Adams, J. M. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell 82, 29–36 (1995).
  Article CAS Google Scholar
• Harvey, M. et al. In vitro growth characteristics of embryo fibroblasts isolated from p53- deficient mice. Oncogene 8, 2457–2467 (1993).
  CAS PubMed Google Scholar
• Alcorta, D. A. et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl Acad. Sci. USA 93, 13742–13747 (1996).
  Article ADS CAS Google Scholar
• el-Deiry, W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 ( 1993).
  Article CAS Google Scholar
• Sherr, C. J. & Weber, J. D. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94–99 (2000).
  Article CAS Google Scholar
• Sakaguchi, K. et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12, 2831– 2841 (1998).
  Article CAS Google Scholar
• Liu, L. et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19, 1202–1209 (1999).
  Article CAS Google Scholar
• Doucas, V., Tini, M., Egan, D. A. & Evans, R. M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl Acad. Sci. USA 96, 2627–2632 ( 1999).
  Article ADS CAS Google Scholar
• Grignani, F. et al. High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 58, 14 –19 (1998).
  CAS PubMed Google Scholar
• Gu, W. & Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595–606 (1997).
  Article CAS Google Scholar
• Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J. & Livingston, D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823–827 (1997).
  Article ADS CAS Google Scholar
• LaMorte, V. J., Dyck, J. A., Ochs, R. L. & Evans, R. M. Localization of nascent RNA and CREB binding protein with the PML- containing nuclear body. Proc. Natl Acad. Sci. USA 95, 4991– 4996 (1998).
  Article ADS CAS Google Scholar
• Ishov, A. M. et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221–234 (1999).
  Article CAS Google Scholar
• Zhong, S. et al. Role of SUMO-1 modified PML in nuclear body formation. Blood 95, 2748–2752 ( 2000).
  CAS PubMed Google Scholar
• Quignon, F. et al. PML induces a novel caspase-independent death process. Nature Genet. 20, 259–265 (1998).
  Article CAS Google Scholar
• Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984–2991 (1998).
  Article CAS Google Scholar
• Livingstone, L. R. et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923–935 (1992).
  Article CAS Google Scholar
• Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C. & Wahl, G. M. Wild-type p53 restores cell-cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70, 937–948 (1992).
  Article CAS Google Scholar
• Zhong, S. et al. A role for PML and the nuclear body in genomic stability. Oncogene 18, 7941–7947 ( 1999).
  Article CAS Google Scholar
• Grignani, F. et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391, 815–818 (1998).
  Article ADS CAS Google Scholar